NCT01270620 Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement Status COMPLETED Phase PHASE4
NCT01265264 Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol Status COMPLETED Phase PHASE2
NCT01264965 Non-cancer Pain and Cognitive Impairment: A Disabling Relationship Status TERMINATED Phase PHASE4
NCT01230177 Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01224119 A Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT01209585 A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01121146 Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty Status COMPLETED Phase NA
NCT01114243 Ultrasound Assessment of Steroid Joint Injections in Juvenile Idiopathic Arthritis Status WITHDRAWN Phase N/A
NCT01107340 AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT01094886 Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement Status COMPLETED Phase PHASE3
NCT01089725 Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study Status TERMINATED Phase PHASE3
NCT01027286 Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty Status COMPLETED Phase PHASE4
NCT01009242 To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate Status COMPLETED Phase PHASE1/PHASE2
NCT01004432 Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Status COMPLETED Phase PHASE3
NCT00944866 Effects of Cox-II Inhibitor on Biochemical Markers in Cardiovascular-related Adverse Effects Status UNKNOWN Phase N/A